Throat Lozenges Market
Throat Lozenges Market Study by Hard Candy Lozenges, Soft Lozenges, and Compressed Lozenges for Sore Throat, Cough & Cold, and Throat Diseases from 2024 to 2034
Analysis of Throat Lozenges Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Throat Lozenges Market Outlook (2024 to 2034)
Worldwide revenue from the sales of throat lozenges is approximated at US$ 5.97 billion in 2024 and is forecasted to rise at a CAGR of 5.1% to reach US$ 9.8 billion by the end of the years 2034.
A throat lozenge, also known as a cough sweet, cachou cough drop, or troche, is a pharmaceutical tablet that melts slowly in the mouth and relieves coughing. The little tablet relieves a sore throat by relaxing and lubricating irritated throat tissues. Rising prevalence of throat diseases is set to boost the throat lozenges market growth.
Throat lozenges have been used to treat throat infections from the beginning of time (1000 BC). Various materials such as honey, herbs, citrus, and spices were used to make the earliest throat lozenges in Egypt. Smith Brothers made cough drops out of these pills in 1852, and Luden made cough drops out of them in 1879.
Cold and cough are common ailments all over the world, and sore throat lozenges are commonly utilized as first-line remedies, which are set to be major market growth driver. Another aspect driving sales of cough sweet is the rising older population, who is more susceptible to infection due to their reduced immunity levels.
Rising popularity of herbal remedies is expected to boost the demand for natural throat lozenges. Consumers are now aware about what ingredients are used in the products. The clean-label marketing is an emerging as a notable throat lozenges market trend, which expected to drive the overall sales growth.
- North America is anticipated to account for 36.3% of the global throat lozenges market share by 2034.
- The Western European throat lozenges market size is calculated at US$ 1.30 billion for 2034.
| Report Attributes | Details |
|---|---|
| Throat Lozenges Market Size (2024E) | US$ 5.97 Billion |
| Forecasted Market Value (2034F) | US$ 9.8 Billion |
| Global Market Growth Rate (2024 to 2034) | 5.1% CAGR |
| South Korea Market Value (2034F) | US$ 408.3 Million |
| Key Companies Profiled |
|
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Market Dynamics are Increasing Consumption of Throat Lozenges?
“Rising Demand for Natural and Herbal Healthcare Products”
Consumer knowledge of the benefits of using the best throat lozenges medicines for the treatment of a variety of respiratory issues is expanding. This is helping in increasing the sales of throat lozenges. Another factor boosting the sales of throat lozenges is the growing desire for natural and herbal goods. Throat lozenges are frequently made with herbs such as ginger or honey, which give a soothing treatment for a sore throat. The rising consumer health awareness is further expected to boost the sales of throat lozenges during the next 10 years.
How Can Market Growth Be Affected to Some Extent?
“Short-term Relief and Strict Regulations Regarding Throat Lozenges Efficiency”
Throat lozenges only provide temporary relief and need to be taken several times during the day. This is one of the factors that may limit the adoption of throat lozenges. Market expansion is also hampered by strict rules regarding the efficiency of sore throat candy medicines.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Comparative Analysis of Related Markets
Throat Lozenges Market
| Key Attributes | Throat Lozenges Market |
|---|---|
| Forecasted Market Value (2034F) | US$ 9.80 Billion |
| Key Trend | Rising demand for herbal formulations |
| Growth Factor | Consumption of lozenges as first line of treatment |
Natural Cold, Cough, and Sore Throat Remedies Market
| Key Attributes | Natural Cold, Cough, and Sore Throat Remedies Market |
|---|---|
| Forecasted Market Value (2034F) | US$ 12 Billion |
| Key Trend | Evolving consumer preferences and increasing popularity of self-healing approach |
| Growth Factor | Rising prevalence of respiratory disorders |
OTC Cough, Cold, and Allergy Medicine Market
| Key Attributes | OTC Cough, Cold and Allergy Medicine Market |
|---|---|
| Forecasted Market Value (2034F) | US$ 70 Billion |
| Key Trend | Growing shift from Rx to OTC |
| Growth Factor | Easy availability of medicine without need of valid prescription |
What Strategy Should New Companies Employ to Reach a Wider Consumer Base?
“Invest in Research and Development to Offer Innovative Formulations”
New companies should focus on the innovation in throat lozenge production. Integration of immune-boosting ingredients such as herbal extracts, vitamin C, and Zinc in the formulations is expected to increase the consumption of sore throat lozenges.
Integration of probiotics in the formulations is also expected to boost the throat health. Thus, investment in research and development initiatives is set to increase profit shares of new companies.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Country-wise Analysis
North America is a major market for sore throat lozenge suppliers. The United States is expected to hold 85.6% of the North American market share by 2034. Furthermore, Asia Pacific is considered to be fastest growing market for throat lozenges due to rising prevalence of respiratory disorders.
What’s Driving Sales of Throat Lozenges in the United States?
“Increasing Availability of Diverse Range of Throat Lozenge Products”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 1.94 Billion |
| Growth Rate (2024 to 2034) | 6% CAGR |
| Projected Value (2034F) | US$ 3.46 Billion |
The United States with its advanced healthcare infrastructure and strong pharmaceutical sector is set to offer ample opportunities for sore throat lozenge suppliers. Several key companies are collaborating together to improve their R&D capabilities and ensure high medical standards, which is expected to drive market growth in the United States. Furthermore, the majority of the share can be linked to the high throat infection rates. The primary factors boosting the throat lozenge sales are the surge in government spending on healthcare and the availability of a diverse range of product options.
What is the Demand Outlook for Throat Lozenges in South Korea?
“Combination of Traditional Formula with Modern Medicine to Boost Profits of Throat Lozenge Producers”
| Attribute | South Korea |
|---|---|
| Market Value (2024E) | US$ 242.1 Million |
| Growth Rate (2024 to 2034) | 5.4% CAGR |
| Projected Value (2034F) | US$ 408.3 Million |
The integration of traditional formula with modern medicine is expected to boost the sales of innovative throat lozenges in South Korea. The rising geriatric population and increasing prevalence of respiratory disorders is further driving the market growth. Pharmaceutical companies and government organizations are forming strategic relationships to create generic medications and raise awareness among healthcare professionals.
Which Aspects are Increasing Consumption of Throat Lozenges in Germany?
“Clean-Label Trend Boosting Sales of Herbal Throat Lozenges”
Rising popularity of organic and clean-label products is driving the demand for herbal throat lozenges in Germany. The shift towards natural remedies is set to increase the demand for cough drops in Germany. Easy availability of cold, cough remedies through online medium is expected to boost the market growth in Germany.
Category-wise Analysis
Hard candy lozenges are available in various flavours and apart from their medicinal use they are also consumed due to their unique taste. Ginger flavoured hard candy lozenges are some of the popular candies among consumers.
Which Type of Throat Lozenge is Widely Consumed?
“Easy Availability and Effective Results Driving Consumption of Hard Candy Lozenges”
| Attribute | Hard Candy Lozenges |
|---|---|
| Segment Value (2024E) | US$ 3.78 Billion |
| Growth Rate (2024 to 2034) | 5.1% CAGR |
| Projected Value (2034F) | US$ 6.23 Billion |
Increasing availability of hard candy lozenges in a variety of flavors, forms, and sizes are making them popular among individuals of all ages. Hard candy lozenges are preferred by the majority of pediatric and geriatric patients, which is attributed to boost sales of hard candy lozenges. Hard candy lozenges do not require a prescription from doctors. Consumers have been conditioned to soothe sore throats with hard candy lozenges rather than seeking medical help, which is driving the demand for hard candy lozenges.
Which Indication Accounts for High Demand for Throat Lozenges?
“High Usage of Throat Lozenges for Sore Throat Treatment”
| Attribute | Sore Throat |
|---|---|
| Segment Value (2024E) | US$ 3.14 Billion |
| Growth Rate (2024 to 2034) | 5.2% CAGR |
| Projected Value (2034F) | US$ 5.21 Billion |
Sore throat is expected to hold the high global market share over the forecast period. Patients with a sore throat are recommended to take throat lozenges. Sore throats can be caused by a virus or a bacterial infection (streptococcus infection). Around 50% of sore throats are caused by viral infections, whereas 15% to 20% are caused by bacterial infections, according to medical experts.
Sore throat is caused by microorganisms such as Mycoplasma pneumonia, Streptococcus, Neisseria gonorrhea, and Chlamydia pneumonia. Symptoms of a sore throat include redness, swelling throat, and swallowing difficulties. The development of promising new medications and growing usage of throat lozenges for sore throat are set to drive the market growth.
Competitive Landscape
Key players in the throat lozenge market are concentrating on continuous innovation and new product launches infused with natural herbs and components to boost their profit shares. Throat lozenge sprays are part of new product lines, which are designed to soothe and ease sore throat symptoms.
- Comvita launched a range of UMF certified Manuka honey-based products for children to cure cough and sore throat in 2019.
- In 2021 Reckitt, a manufacturer of over-the-counter cough and cold medicines, announced the launch of Mucinex InstaSoothe, a new line of products.
Key Segments of Throat Lozenges Market Research
-
By Type :
- Hard Candy Lozenges
- Soft Lozenges
- Compressed Lozenges
-
By Indication :
- Sore Throat
- Cough & Cold
- Throat Diseases
-
By Distribution Channel :
- Hospital Pharmacies
- Hypermarket/Supermarkets
- Online Pharmacies
- Others
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand Side Trends 1.3. Supply Side Trends 1.4. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 2.3. Inclusions/Exclusions 3. Key Market Trends 3.1. Key Trends Impacting the Market 3.2. Product modifications /Innovation 4. Key Success Factors 4.1. Strategic Developments 4.2. Key regulations 4.3. List of Manufacturers and Providers 5. Market Background 5.1. Macro-Economic Factors 5.1.1. Global GDP outlook 5.1.2. Increasing R&D Expenditure 5.2. Forecast Factors - Relevance & Impact 5.2.1. New product launches 5.2.2. Cost of Products 5.3. Market Dynamics 5.3.1. Drivers 5.3.2. Restraints 5.3.3. Opportunity Analysis 6. COVID19 Crisis Analysis 6.1. Current COVID19 Statistics and Probable Future Impact 6.2. Current GDP Projection and Probable Impact 6.3. Current Economic Projection as Compared to 2008 Economic analysis 6.4. COVID19 and Impact Analysis 6.4.1. Revenue By Type 6.4.2. Revenue By Indication 6.4.3. Revenue By Country 6.5. 2020 Market Scenario 6.6. Quarter by Quarter Forecast 6.7. Projected Recovery Quarter 7. Global Market Volume (Units) Analysis 2018-2023 and Forecast, 2024-2034 7.1. Historical Market Volume (Units) Analysis, 2018-2023 7.2. Current and Future Market Volume (Units) Projections, 2024-2034 7.2.1. Y-o-Y Growth Trend Analysis 8. Global Market - Pricing Analysis 8.1. Regional Pricing Analysis By Type 8.2. Pricing Break-up 8.2.1. Manufacturer Level Pricing 8.2.2. Distributor Level Pricing 8.3. Global Average Pricing Analysis Benchmark 9. Global Market Value Analysis 2018-2023 and Forecast, 2024-2034 9.1. Historical Market Value (US$ Mn) Analysis, 2018-2023 9.2. Current and Future Market Value (US$ Mn) Projections, 2024-2034 9.2.1. Y-o-Y Growth Trend Analysis 9.2.2. Absolute $ Opportunity Analysis 10. Global Market Analysis 2018-2023 and Forecast 2024-2034, by Type 10.1. Introduction / Key Findings 10.2. Historical Market Size (US$ Mn) Analysis By Products & Services, 2018-2023 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Type, 2024-2034 10.3.1. Hard Candy Lozenges 10.3.2. Soft Lozenges 10.3.3. Compressed Lozenges 10.4. Market Attractiveness Analysis By Type 11. Global Market Analysis 2018-2023 and Forecast 2024-2034, by Indication 11.1. Introduction / Key Findings 11.2. Historical Market Size (US$ Mn) Analysis By Indication , 2018-2023 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Indication , 2024-2034 11.3.1. Sore Throat 11.3.2. Cough & Cold 11.3.3. Throat Diseases 11.4. Market Attractiveness Analysis By Indication 12. Global Market Analysis 2018-2023 and Forecast 2024-2034, by Region 12.1. Introduction 12.2. Historical Market Size (US$ Mn) Analysis By Region, 2018-2023 12.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2024-2034 12.3.1. North America 12.3.2. Latin America 12.3.3. Europe 12.3.4. East Asia 12.3.5. South Asia 12.3.6. Oceania 12.3.7. Middle East and Africa (MEA) 12.4. Market Attractiveness Analysis By Region 13. North America Market Analysis 2018-2023 and Forecast 2024-2034 13.1. Introduction 13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2023 13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2034 13.3.1. By Country 13.3.1.1. U.S. 13.3.1.2. Canada 13.3.2. By Type 13.3.3. By Indication 13.4. Market Attractiveness Analysis 13.5. Key Market Participants - Intensity Mapping 13.6. Drivers and Restraints - Impact Analysis 14. Latin America Market Analysis 2018-2023 and Forecast 2024-2034 14.1. Introduction 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2023 14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2034 14.3.1. By Country 14.3.1.1. Brazil 14.3.1.2. Mexico 14.3.1.3. Argentina 14.3.1.4. Rest of Latin America 14.3.2. By Type 14.3.3. By Indication 14.4. Market Attractiveness Analysis 14.5. Key Market Participants - Intensity Mapping 14.6. Drivers and Restraints - Impact Analysis 15. Europe Market Analysis 2018-2023 and Forecast 2024-2034 15.1. Introduction 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2023 15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2034 15.3.1. By Country 15.3.1.1. Germany 15.3.1.2. Italy 15.3.1.3. France 15.3.1.4. U.K. 15.3.1.5. Spain 15.3.1.6. Russia 15.3.1.7. Rest of Europe 15.3.2. By Type 15.3.3. By Indication 15.4. Market Attractiveness Analysis 15.5. Key Market Participants - Intensity Mapping 15.6. Drivers and Restraints - Impact Analysis 16. South Asia Market Analysis 2018-2023 and Forecast 2024-2034 16.1. Introduction 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2023 16.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2034 16.3.1. By Country 16.3.1.1. India 16.3.1.2. Thailand 16.3.1.3. Indonesia 16.3.1.4. Malaysia 16.3.1.5. Rest of South Asia 16.3.2. By Type 16.3.3. By Indication 16.4. Market Attractiveness Analysis 16.5. Key Market Participants - Intensity Mapping 16.6. Drivers and Restraints - Impact Analysis 17. East Asia Market Analysis 2018-2023 and Forecast 2024-2034 17.1. Introduction 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2023 17.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2034 17.3.1. By Country 17.3.1.1. China 17.3.1.2. Japan 17.3.1.3. South Korea 17.3.1.4. Rest of East Asia 17.3.2. By Type 17.3.3. By Indication 17.4. Market Attractiveness Analysis 17.5. Key Market Participants - Intensity Mapping 17.6. Drivers and Restraints - Impact Analysis 18. Oceania Market Analysis 2018-2023 and Forecast 2024-2034 18.1. Introduction 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2023 18.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2034 18.3.1. By Country 18.3.1.1. Australia 18.3.1.2. New Zealand 18.3.2. By Type 18.3.3. By Indication 18.4. Market Attractiveness Analysis 18.5. Key Market Participants - Intensity Mapping 18.6. Drivers and Restraints - Impact Analysis 19. Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2034 19.1. Introduction 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2018-2023 19.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2024-2034 19.3.1. By Country 19.3.1.1. GCC Countries 19.3.1.2. South Africa 19.3.1.3. Rest of Middle East and Africa 19.3.2. By Type 19.3.3. By Indication 19.4. Market Attractiveness Analysis 19.5. Drivers and Restraints - Impact Analysis 20. Key and Emerging Countries Market Analysis 2018-2023 and Forecast 2024-2034 20.1. Introduction 20.1.1. Market Value Proportion Analysis, By Key Countries 20.1.2. Global Vs. Country Growth Comparison 20.2. U.S. Market Analysis 20.2.1. By Type 20.2.2. By Indication 20.3. Canada Market Analysis 20.3.1. By Type 20.3.2. By Indication 20.4. Mexico Market Analysis 20.4.1. By Type 20.4.2. By Indication 20.5. Brazil Market Analysis 20.5.1. By Type 20.5.2. By Indication 20.6. U.K. Market Analysis 20.6.1. By Type 20.6.2. By Indication 20.7. Germany Market Analysis 20.7.1. By Type 20.7.2. By Indication 20.8. France Market Analysis 20.8.1. By Type 20.8.2. By Indication 20.9. Italy Market Analysis 20.9.1. By Type 20.9.2. By Indication 20.10. Spain Market Analysis 20.10.1. By Type 20.10.2. By Indication 20.11. BENELUX Market Analysis 20.11.1. By Type 20.11.2. By Indication 20.12. Russia Market Analysis 20.12.1. By Type 20.12.2. By Indication 20.13. China Market Analysis 20.13.1. By Type 20.13.2. By Indication 20.14. Japan Market Analysis 20.14.1. By Type 20.14.2. By Indication 20.15. South Korea Market Analysis 20.15.1. By Type 20.15.2. By Indication 20.16. India Market Analysis 20.16.1. By Type 20.16.2. By Indication 20.17. ASEAN Market Analysis 20.17.1. By Type 20.17.2. By Indication 20.18. Australia Market Analysis 20.18.1. By Type 20.18.2. By Indication 20.19. New Zealand Market Analysis 20.19.1. By Type 20.19.2. By Indication 20.20. GCC Countries Market Analysis 20.20.1. By Type 20.20.2. By Indication 20.21. Turkey Market Analysis 20.21.1. By Type 20.21.2. By Indication 20.22. South Africa Market Analysis 20.22.1. By Type 20.22.2. By Indication 21. Market Structure Analysis 21.1. Market Analysis by Tier of Companies 21.2. Market Concentration 21.3. Market Share Analysis of Top Players 21.4. Market Presence Analysis 21.4.1. By Regional footprint of Players 21.4.2. Product foot print by Players 21.4.3. Channel Foot Print by Players 22. Competition Analysis 22.1. Competition Dashboard 22.2. Competition Benchmarking 22.3. Competition Deep dive 22.3.1. Bliss GVS Pharma Ltd. 22.3.1.1. Overview 22.3.1.2. Product Portfolio 22.3.1.3. Profitability by Market Segments (Product/Channel/Region) 22.3.1.4. Sales Footprint 22.3.1.5. Strategy Overview 22.3.1.5.1. Marketing Strategy 22.3.1.5.2. Product Strategy 22.3.1.5.3. Channel Strategy 22.3.2. GlaxoSmithKline Plc 22.3.2.1. Overview 22.3.2.2. Product Portfolio 22.3.2.3. Profitability by Market Segments (Product/Channel/Region) 22.3.2.4. Sales Footprint 22.3.2.5. Strategy Overview 22.3.2.5.1. Marketing Strategy 22.3.2.5.2. Product Strategy 22.3.2.5.3. Channel Strategy 22.3.3. Honibe 22.3.3.1. Overview 22.3.3.2. Product Portfolio 22.3.3.3. Profitability by Market Segments (Product/Channel/Region) 22.3.3.4. Sales Footprint 22.3.3.5. Strategy Overview 22.3.3.5.1. Marketing Strategy 22.3.3.5.2. Product Strategy 22.3.3.5.3. Channel Strategy 22.3.4. Prestige Consumer Healthcare Inc. 22.3.4.1. Overview 22.3.4.2. Product Portfolio 22.3.4.3. Profitability by Market Segments (Product/Channel/Region) 22.3.4.4. Sales Footprint 22.3.4.5. Strategy Overview 22.3.4.5.1. Marketing Strategy 22.3.4.5.2. Product Strategy 22.3.4.5.3. Channel Strategy 22.3.5. Reckitt Benckiser Group Plc 22.3.5.1. Overview 22.3.5.2. Product Portfolio 22.3.5.3. Profitability by Market Segments (Product/Channel/Region) 22.3.5.4. Sales Footprint 22.3.5.5. Strategy Overview 22.3.5.5.1. Marketing Strategy 22.3.5.5.2. Product Strategy 22.3.5.5.3. Channel Strategy 22.3.6. Ricola AG 22.3.6.1. Overview 22.3.6.2. Product Portfolio 22.3.6.3. Profitability by Market Segments (Product/Channel/Region) 22.3.6.4. Sales Footprint 22.3.6.5. Strategy Overview 22.3.6.5.1. Marketing Strategy 22.3.6.5.2. Product Strategy 22.3.6.5.3. Channel Strategy 22.3.7. Sanofi S.A 22.3.7.1. Overview 22.3.7.2. Product Portfolio 22.3.7.3. Profitability by Market Segments (Product/Channel/Region) 22.3.7.4. Sales Footprint 22.3.7.5. Strategy Overview 22.3.7.5.1. Marketing Strategy 22.3.7.5.2. Product Strategy 22.3.7.5.3. Channel Strategy 22.3.8. Thornton & Ross Ltd. 22.3.8.1. Overview 22.3.8.2. Product Portfolio 22.3.8.3. Profitability by Market Segments (Product/Channel/Region) 22.3.8.4. Sales Footprint 22.3.8.5. Strategy Overview 22.3.8.5.1. Marketing Strategy 22.3.8.5.2. Product Strategy 22.3.8.5.3. Channel Strategy 22.3.9. Traditional Medicinals, Inc. 22.3.9.1. Overview 22.3.9.2. Product Portfolio 22.3.9.3. Profitability by Market Segments (Product/Channel/Region) 22.3.9.4. Sales Footprint 22.3.9.5. Strategy Overview 22.3.9.5.1. Marketing Strategy 22.3.9.5.2. Product Strategy 22.3.9.5.3. Channel Strategy 23. Assumptions and Acronyms Used 24. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Volume (‘000 Units) Analysis and Opportunity Assessment 2018-2034, By Type
Table 02: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Type
Table 03: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Indication
Table 04: Global Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Region
Table 05: North America Market Value (US$ Mn) Analysis 2018-2023 and Forecast 2024-2034, By Country
Table 06: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Type
Table 07: North America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Indication
Table 08: Latin America Market Value (US$ Mn) Analysis 2018-2023 and Forecast 2024-2034, By Country
Table 09: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Type
Table 10: Latin America Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Indication
Table 11: Europe Market Value (US$ Mn) Analysis 2018-2023 and Forecast 2024-2034, By Country
Table 12: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Type
Table 13: Europe Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Indication
Table 14: South Asia Market Value (US$ Mn) Analysis 2018-2023 and Forecast 2024-2034, By Country
Table 15: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Type
Table 16: South Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Indication
Table 17: East Asia Market Value (US$ Mn) Analysis 2018-2023 and Forecast 2024-2034, By Country
Table 18: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Type
Table 19: East Asia Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Indication
Table 20: Oceania Market Value (US$ Mn) Analysis 2018-2023 and Forecast 2024-2034, By Country
Table 21: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Type
Table 22: Oceania Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Indication
Table 23: Middle East and Africa Market Value (US$ Mn) Analysis 2018-2023 and Forecast 2024-2034, By Country
Table 24: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Type
Table 25: Middle East and Africa Market Value (US$ Mn) Analysis and Opportunity Assessment 2018-2034, By Indication
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Volume (in 000' Units) Analysis, 2018-2023
Figure 02: Global Market Volume Forecast (in 000' Units), 2024-2034
Figure 03: Pricing Analysis (US$) Per Product, By Region, 2020
Figure 04: Pricing Analysis (US$) Per Product, By Region, 2020
Figure 05: Global Market Value Analysis (US$ Mn), 2018-2023
Figure 06: Global Market Value Forecast (US$ Mn), 2024-2034
Figure 07: Global Market Absolute $ Opportunity, 2024-2034
Figure 08: Global Market Share Analysis (%), By Type, 2024-2034
Figure 09: Global Market Y-o-Y Analysis (%), By Type, 2024-2034
Figure 10: Global Market Attractiveness Analysis by Type, 2024-2034
Figure 11: Global Market Share Analysis (%), By Indication, 2024-2034
Figure 12: Global Market Y-o-Y Analysis (%), By Indication, 2024-2034
Figure 13: Global Market Attractiveness Analysis by Indication, 2024-2034
Figure 14: Global Market Share Analysis (%), By Region, 2024-2034
Figure 15: Global Market Y-o-Y Analysis (%), By Region, 2024-2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024-2034
Figure 17: North America Market Value Share, By Type, 2024 (E)
Figure 18: North America Market Value Share, By Indication, 2024 (E)
Figure 19: North America Market Value Share, By Country, 2024 (E)
Figure 20: North America Market Value Analysis (US$ Mn), 2018-2023
Figure 21: North America Market Value Forecast (US$ Mn), 2024-2034
Figure 22: North America Market Attractiveness Analysis by Type, 2024-2034
Figure 23: North America Market Attractiveness Analysis by Indication, 2024-2034
Figure 24: North America Market Attractiveness Analysis by Country, 2024-2034
Figure 25: Latin America Market Value Share, By Type, 2024 (E)
Figure 26: Latin America Market Value Share, By Indication, 2024 (E)
Figure 27: Latin America Market Value Share, By Country, 2024 (E)
Figure 28: Latin America Market Value Analysis (US$ Mn), 2018-2023
Figure 29: Latin America Market Value Forecast (US$ Mn), 2024-2034
Figure 30: Latin America Market Attractiveness Analysis by Type, 2024-2034
Figure 31: Latin America Market Attractiveness Analysis by Indication, 2024-2034
Figure 32: Latin America Market Attractiveness Analysis by Country, 2024-2034
Figure 33: Europe Market Value Share, By Type, 2024 (E)
Figure 34: Europe Market Value Share, By Indication, 2024 (E)
Figure 35: Europe Market Value Share, By Country, 2024 (E)
Figure 36: Europe Market Value Analysis (US$ Mn), 2018-2023
Figure 37: Europe Market Value Forecast (US$ Mn), 2024-2034
Figure 38: Europe Market Attractiveness Analysis by Type, 2024-2034
Figure 39: Europe Market Attractiveness Analysis by Indication, 2024-2034
Figure 40: Europe Market Attractiveness Analysis by Country, 2024-2034
Figure 41: South Asia Market Value Share, By Type, 2024 (E)
Figure 42: South Asia Market Value Share, By Indication, 2024 (E)
Figure 43: South Asia Market Value Share, By Country, 2024 (E)
Figure 44: South Asia Market Value Analysis (US$ Mn), 2018-2023
Figure 45: South Asia Market Value Forecast (US$ Mn), 2024-2034
Figure 46: South Asia Market Attractiveness Analysis by Type, 2024-2034
Figure 47: South Asia Market Attractiveness Analysis by Indication, 2024-2034
Figure 48: South Asia Market Attractiveness Analysis by Country, 2024-2034
Figure 49: East Asia Market Value Share, By Type, 2024 (E)
Figure 50: East Asia Market Value Share, By Indication, 2024 (E)
Figure 51: East Asia Market Value Share, By Country, 2024 (E)
Figure 52: East Asia Market Value Analysis (US$ Mn), 2018-2023
Figure 53: East Asia Market Value Forecast (US$ Mn), 2024-2034
Figure 54: East Asia Market Attractiveness Analysis by Type, 2024-2034
Figure 55: East Asia Market Attractiveness Analysis by Indication, 2024-2034
Figure 56: East Asia Market Attractiveness Analysis by Country, 2024-2034
Figure 57: Oceania Market Value Share, By Type, 2024 (E)
Figure 58: Oceania Market Value Share, By Indication, 2024 (E)
Figure 59: Oceania Market Value Share, By Country, 2024 (E)
Figure 60: Oceania Market Value Analysis (US$ Mn), 2018-2023
Figure 61: Oceania Market Value Forecast (US$ Mn), 2024-2034
Figure 62: Oceania Market Attractiveness Analysis by Type, 2024-2034
Figure 63: Oceania Market Attractiveness Analysis by Indication, 2024-2034
Figure 64: Oceania Market Attractiveness Analysis by Country, 2024-2034
Figure 65: Middle East and Africa Market Value Share, By Type, 2024 (E)
Figure 66: Middle East and Africa Market Value Share, By Indication, 2024 (E)
Figure 67: Middle East and Africa Market Value Share, By Country, 2024 (E)
Figure 68: Middle East and Africa Market Value Analysis (US$ Mn), 2018-2023
Figure 69: Middle East and Africa Market Value Forecast (US$ Mn), 2024-2034
Figure 70: Middle East and Africa Market Attractiveness Analysis by Type, 2024-2034
Figure 71: Middle East and Africa Market Attractiveness Analysis by Indication, 2024-2034
Figure 72: Middle East and Africa Market Attractiveness Analysis by Country, 2024-2034
Figure 73: U. S. Market Value Analysis (US$ Mn), 2024 & 2034
Figure 74: U. S. Market Value Share, By Type, 2024 (E)
Figure 75: U. S. Market Value Share, By Indication, 2024 (E)
Figure 76: Canada Market Value Analysis (US$ Mn), 2024 & 2034
Figure 77: Canada Market Value Share, By Type, 2024 (E)
Figure 78: Canada Market Value Share, By Indication, 2024 (E)
Figure 79: Mexico Market Value Analysis (US$ Mn), 2024 & 2034
Figure 80: Mexico Market Value Share, By Type, 2024 (E)
Figure 81: Mexico Market Value Share, By Indication, 2024 (E)
Figure 82: Brazil Market Value Analysis (US$ Mn), 2024 & 2034
Figure 83: Brazil Market Value Share, By Type, 2024 (E)
Figure 84: Brazil Market Value Share, By Indication, 2024 (E)
Figure 85: U. K. Market Value Analysis (US$ Mn), 2024 & 2034
Figure 86: U. K. Market Value Share, By Type, 2024 (E)
Figure 87: U. K. Market Value Share, By Indication, 2024 (E)
Figure 88: Germany Market Value Analysis (US$ Mn), 2024 & 2034
Figure 89: Germany Market Value Share, By Type, 2024 (E)
Figure 90: Germany Market Value Share, By Indication, 2024 (E)
Figure 91: France Market Value Analysis (US$ Mn), 2024 & 2034
Figure 92: France Market Value Share, By Type, 2024 (E)
Figure 93: France Market Value Share, By Indication, 2024 (E)
Figure 94: Italy Market Value Analysis (US$ Mn), 2024 & 2034
Figure 95: Italy Market Value Share, By Type, 2024 (E)
Figure 96: Italy Market Value Share, By Indication, 2024 (E)
Figure 97: Spain Market Value Analysis (US$ Mn), 2024 & 2034
Figure 98: Spain Market Value Share, By Type, 2024 (E)
Figure 99: Spain Market Value Share, By Indication, 2024 (E)
Figure 100: Russia Market Value Analysis (US$ Mn), 2024 & 2034
Figure 101: Russia Market Value Share, By Type, 2024 (E)
Figure 102: Russia Market Value Share, By Indication, 2024 (E)
Figure 103: China Market Value Analysis (US$ Mn), 2024 & 2034
Figure 104: China Market Value Share, By Type, 2024 (E)
Figure 105: China Market Value Share, By Indication, 2024 (E)
Figure 106: Japan Market Value Analysis (US$ Mn), 2024 & 2034
Figure 107: Japan Market Value Share, By Type, 2024 (E)
Figure 108: Japan Market Value Share, By Indication, 2024 (E)
Figure 109: South Korea Market Value Analysis (US$ Mn), 2024 & 2034
Figure 110: South Korea Market Value Share, By Type, 2024 (E)
Figure 111: South Korea Market Value Share, By Indication, 2024 (E)
Figure 112: India Market Value Analysis (US$ Mn), 2024 & 2034
Figure 113: India Market Value Share, By Type, 2024 (E)
Figure 114: India Market Value Share, By Indication, 2024 (E)
Figure 115: ASEAN Market Value Analysis (US$ Mn), 2024 & 2034
Figure 116: ASEAN Market Value Share, By Type, 2024 (E)
Figure 117: ASEAN Market Value Share, By Indication, 2024 (E)
Figure 118: Australia Market Value Analysis (US$ Mn), 2024 & 2034
Figure 119: Australia Market Value Share, By Type, 2024 (E)
Figure 120: Australia Market Value Share, By Indication, 2024 (E)
Figure 121: New Zealand Market Value Analysis (US$ Mn), 2024 & 2034
Figure 122: New Zealand Market Value Share, By Type, 2024 (E)
Figure 123: New Zealand Market Value Share, By Indication, 2024 (E)
Figure 124: GCC Countries Market Value Analysis (US$ Mn), 2024 & 2034
Figure 125: GCC Countries Market Value Share, By Type, 2024 (E)
Figure 126: GCC Countries Market Value Share, By Indication, 2024 (E)
Figure 127: Turkey Market Value Analysis (US$ Mn), 2024 & 2034
Figure 128: Turkey Market Value Share, By Type, 2024 (E)
Figure 129: Turkey Market Value Share, By Indication, 2024 (E)
Figure 130: South Africa Market Value Analysis (US$ Mn), 2024 & 2034
Figure 131: South Africa Market Value Share, By Type, 2024 (E)
Figure 132: South Africa Market Value Share, By Indication, 2024 (E)
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the throat lozenges market in 2024?
The global throat lozenges market is evaluated at US$ 5.97 billion by 2034.
What is the future of throat lozenges?
Sales of throat lozenges are forecasted to rise at a CAGR of 5.1% from 2024 to 2034.
What are anticipated sales of throat lozenges for 2034?
The market for throat lozenges is projected to reach US$ 9.8 billion by 2034.
Which types of throat lozenges are widely consumed?
Sales of hard candy throat lozenges are approximated at US$ 3.7 billion in 2024.
What size of the market in South Korea projected to reach by 2034?
The South Korea market is anticipated to reach US$ 408.3 million by 2034.
Who are top producers of throat lozenges?
Some of the leading manufacturers include Bliss GVS Pharma Ltd., GlaxoSmithKline Plc., and Reckitt Benckiser Group Plc.
Throat Lozenges Market